Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3283287 | Clinical Gastroenterology and Hepatology | 2012 | 6 Pages |
Abstract
Alpha1-antitrypsin (A1AT) deficiency is an autosomal codominant disease that can cause chronic liver disease, cirrhosis, and hepatocellular carcinoma in children and adults and increases risk for emphysema in adults. The development of symptomatic disease varies; some patients have life-threatening symptoms in childhood, whereas others remain asymptomatic and healthy into old age. As a result of this variability, patients present across multiple disciplines, including pediatrics, adult medicine, hepatology, genetics, and pulmonology. This can give physicians the mistaken impression that the condition is less common than it actually is and can lead to fragmented care that omits critical interventions commonly performed by other specialists. We sought to present a rational approach for hepatologists to manage adult patients with A1AT deficiency.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
David R. Nelson, Jeffrey Teckman, Adrian M. Di Bisceglie, David A. Brenner,